Case scenario
You are working in a compounding pharmacy and are presented with a prescription for an oral tacrolimus suspension for Patrick, aged 8, who has had an organ transplant. Due to the hazardous nature of tacrolimus, compounding the medicine requires
strict adherence to safety guidelines. You begin by reviewing the prescription and consulting the stability data and available formulations for compounded oral tacrolimus suspension. You gather the necessary ingredients and equipment required.
Learning objectivesAfter reading this article, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.3, 1.4, 1.5, 1.6, 3.4, 4.5 Accreditation number: CAP2406AMDS Accreditation expiry: 31/05/2027 |
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.
Introduction
Hazardous medicines play an important role in modern healthcare, offering treatment for diverse diseases and conditions, such as cancer or the prevention of transplant rejection. However, their handling and compounding pose substantial risks to healthcar
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.


Team PSA 2026: Caroline Diamantis FPS, Prof Mark Naunton MPS and Bridget Totterman MPS[/caption]
A/Prof Fei Sim and Prof Mark Naunton[/caption]

Clinical features
Warm compresses are the cornerstone of treatment, helping to soften the lesion, bring pus to the surface and encourage spontaneous drainage. A clean face cloth soaked in warm (not hot) water should be applied to the closed eyelid for 2–5 minutes, twice daily during the active phase. Once the stye begins to drain, any discharge should be gently wiped away using a clean, warm washcloth. After resolution, continuing warm compresses once daily may help prevent recurrence.2 







